Although PPMS shares the EWSR1::CREB1 fusion with AFH, there have been no reports indicating that doxorubicin can produce a significant therapeutic effect in PPMS with EWSR1::CREB1 fusion. This evidence concerns the gene CREB1 and primary progressive multiple sclerosis.